Company / Assets per Share
LENZ Therapeutics, Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$11.12
FY2025
5-year range
$5.87 / $35.92
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
#89 of 210
Health Care
What the data says
At $11.12, LENZ Therapeutics, Inc.'s assets per share ranks #89 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 6 years, ranging from $5.87 in FY2022 to $35.92 in FY2023.
Based on SEC 10-K filings.
11.12 in FY2025 with a 5-year CAGR of +2.4%.
Declined from $35.92 to $11.12 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +23.7%
- 5-Year CAGR
- +2.4%
- 10-Year CAGR
- -
Sector benchmark
#89 of 210 in Health CareTop 42% of 210This company $11.12 Sector average $353.15
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 9.9% year-over-year.
- Ranks #89 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.12 | +9.9% |
| FY2024 | $10.12 | -71.8% |
| FY2023 | $35.92 | +512.4% |
| FY2022 | $5.87 | -57.8% |
| FY2021 | $13.90 | +40.7% |
| FY2020 | $9.88 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026